The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

Overview

Journal J Thorac Oncol

Publisher Elsevier

Specialties Oncology
Pulmonary Medicine

Date 2016 Jan 15

PMID 26762738

Citations 2017

Authors

Peter Goldstraw

Kari Chansky

John Crowley

Ramon Rami-Porta

Hisao Asamura

Wilfried E E Eberhardt

Andrew G Nicholson

Patti Groome

Alan Mitchell

Vanessa Bolejack

Affiliations

Soon will be listed here.

Abstract

The IASLC Staging and Prognostic Factors Committee has collected a new database of 94,708 cases donated from 35 sources in 16 countries around the globe. This has now been analysed by our statistical partners at Cancer Research And Biostatistics and, in close collaboration with the members of the committee proposals have been developed for the T, N, and M categories of the 8th edition of the TNM Classification for lung cancer due to be published late 2016. In this publication we describe the methods used to evaluate the resultant Stage groupings and the proposals put forward for the 8th edition.

Citing Articles

Research trends of neoadjuvant therapy in lung cancer: a bibliometric analysis.

Geng X, Jiang Y, Zeng Y, Cao W, Lu Y, Liang Y Discov Oncol. 2025; 16(1):321.

PMID: 40088301 DOI: 10.1007/s12672-025-02011-6.

CT-based radiomics-deep learning model predicts occult lymph node metastasis in early-stage lung adenocarcinoma patients: A multicenter study.

Yin X, Lu Y, Cui Y, Zhou Z, Wen J, Huang Z Chin J Cancer Res. 2025; 37(1):12-27.

PMID: 40078558 PMC: 11893343. DOI: 10.21147/j.issn.1000-9604.2025.01.02.

Lung Cancer-Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature).

Smolarz B, Lukasiewicz H, Samulak D, Piekarska E, Kolacinski R, Romanowicz H Int J Mol Sci. 2025; 26(5).

PMID: 40076671 PMC: 11900952. DOI: 10.3390/ijms26052049.

Validation for revision of the stage IIIA(T1N2) in the forthcoming ninth edition of the TNM classification for lung cancer.

Wu T, Cai J, Li Y, Xie R, Chen K BMC Cancer. 2025; 25(1):446.

PMID: 40075384 PMC: 11905661. DOI: 10.1186/s12885-024-13364-6.

The impact of extent of nodal involvement on stage IIIA (N2) non-small cell lung cancer outcomes.

Wong L, Tsai L, He H, Elliott I, Berry M JTCVS Open. 2025; 23:256-265.

PMID: 40061550 PMC: 11883707. DOI: 10.1016/j.xjon.2024.11.018.